ACAMPROSATE CALCIUM-333 MG.

ACAMPROSATE CALCIUM-333 MG. Specification

Pacakaging (Quantity Per Box)
20x10 Tablets

Origin of Medicine
India

Drug Type
Health Supplements

Physical Form
Tablets

Dosage Guidelines
As directed by the physician

Suitable For
Teenagers, Women, Adults, Aged Person

Storage Instructions
Dry Place

ACAMPROSATE CALCIUM-333 MG. Trade Information

Minimum Order Quantity
100 Pieces

Supply Ability
5000 Pieces Per Month

Delivery Time
7 Days

About ACAMPROSATE CALCIUM-333 MG.

Alcoholism : A killer addiction.

Get your patients out from this addiction with......

Enhances abstinence, improves life.

Highly appreciable in alcohol dependence

- Decreases the rate of relapse and helps maintain abstinence

- Improves life expectancy and reduces lifetime medical costs in alcoholic patients

- Offers a favorable safety profile.

Acamprosate also helps decrease alcohol dependence. It decreases the rate of relapse and helps

maintain abstinence. Its mechanism of action is unknown. It improves life expectancy and reduces

lifetime medical costs in alcoholic patients. It has a favorable safety profile.

[Jaurigue MM, Cappell MS. : World J Gastroenterol. 2014 Mar 7;20(9):2143-58]

* An approved medication in advanced continents

Acamprosate has been approved for the treatment of alcohol dependence in Europe since 1989, while the US Food and Drug Administration (FDA) has only recently approved the use of acamprosate for alcohol dependence in 2004.

[Yahn SL, Watterson LR, Olive MF. : Subst Abuse. 2013;6:1-12]

* Well compared with naltrexone and disulfiram

- Feasible prescription in presence of hepatitis or liver diseases

In comparison with naltrexone and disulfiram, which are the other FDA-approved treatments for

alcohol dependence, acamprosate is unique in that it is not metabolized by the liver and is also not

impacted by alcohol use, so can be administered to patients with hepatitis or liver disease (a common comorbid condition among individuals with alcohol dependence) and to patients who continue drinking alcohol.

[Witkiewitz K1, Saville K, Hamreus K. : Ther Clin Risk Manag. 2012;8:45-53]

* Exhibits no serious health risks, no abuse potential

* Free from drug-drug interactions

More specifically, it does not appear to interact with alcohol or compounds commonly prescribed for treating alcoholism (e.g.,disulfiram, antidepressants, anxiolytics, neuroleptics, or hypnotics) nor does it appear to interact adversely with naltrexone.

[Barbara J. Mason and Charles J. Heyser : CNS Neurol Disord Drug Targets. 2010 March ; 9(1): 2332

* Indication & Dosage :

- Alcoholism (four to six tablets (333 mg each) per day i.e. two tablets two to three times daily)

- Sensorineural tinnitus (333 mg 1 tab TDS for 45 days)

- Autistic spectrum disorder(333 mg/day to a maximum of 1,332 mg/day, divided three times daily)

Tell us about your requirement